Keymed Biosciences (HKSE:02162) Days Sales Outstanding : 73.46 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Keymed Biosciences Days Sales Outstanding?

Keymed Biosciences's average Accounts Receivable for the six months ended in Dec. 2023 was HK$11.9 Mil. Keymed Biosciences's Revenue for the six months ended in Dec. 2023 was HK$29.5 Mil. Hence, Keymed Biosciences's Days Sales Outstanding for the six months ended in Dec. 2023 was 73.46.

The historical rank and industry rank for Keymed Biosciences's Days Sales Outstanding or its related term are showing as below:

HKSE:02162' s Days Sales Outstanding Range Over the Past 10 Years
Min: 11.19 Med: 16.59 Max: 16.59
Current: 11.19

During the past 5 years, Keymed Biosciences's highest Days Sales Outstanding was 16.59. The lowest was 11.19. And the median was 16.59.

HKSE:02162's Days Sales Outstanding is ranked better than
94.75% of 895 companies
in the Biotechnology industry
Industry Median: 72.67 vs HKSE:02162: 11.19

Keymed Biosciences's Days Sales Outstanding increased from Dec. 2022 (0.00) to Dec. 2023 (73.46).

Keymed Biosciences Days Sales Outstanding Historical Data

The historical data trend for Keymed Biosciences's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Keymed Biosciences Days Sales Outstanding Chart

Keymed Biosciences Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

16.59

Keymed Biosciences Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial				-	-	-	3.14	73.46

Competitive Comparison of Keymed Biosciences's Days Sales Outstanding

For the Biotechnology subindustry, Keymed Biosciences's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Keymed Biosciences's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Keymed Biosciences's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Keymed Biosciences's Days Sales Outstanding falls into.

Keymed Biosciences Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Keymed Biosciences's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0	+	17.6)	/	1 )	/	387.302	*	365
=	17.6					/	387.302	*	365
=	16.59

Keymed Biosciences's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (6.148	+	17.6)	/	2 )	/	29.5	*	365 / 2
=	11.874					/	29.5	*	365 / 2
=	73.46

Keymed Biosciences (HKSE:02162) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Keymed Biosciences Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Keymed Biosciences's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Keymed Biosciences (HKSE:02162) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Keymed Biosciences Inc (HKSE:02162) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

64Z:Germany

Address

No. 18 BioTown Middle Road, Building D2, Tianfu International BioTown, Chengdu, Sichuan, CHN, 610219

Website

https://www.keymedbio.com

Keymed Biosciences Inc is a biotechnology company with multiple clinical-stage assets. The company is focused on the in-house discovery and development of innovative biological therapies that address large underserved medical needs in the autoimmune and oncology therapeutic areas. The Group is engaged in biopharmaceutical research and development, which is regarded as a single reportable segment. Geographically, it operates in Hong Kong & Mainland China, out of which the majority is from Mainland China.

Keymed Biosciences (HKSE:02162) Headlines

No Headlines